EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice

Huijun Yuan, Shaoyi Chen, Matthew R Duncan, Juan Pablo de Rivero Vaccari, Robert W Keane, W Dalton Dietrich, Tsung-Han Chou, Merline Benny, Augusto F Schmidt, Karen Young, Kevin K Park, Vittorio Porciatti und 2 weitere

Angiogenesis · 2024

DOI: 10.1007/s10456-024-09917-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiogenesis, 2024. Verfasst von Huijun Yuan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics/Division of Neonatology, Batchelor Children's Research Institute and Holtz Children's Hospital, University of Miami Miller S…. Hauptthemen laut MEDLINE: Oxygen, Retinopathy of Prematurity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retinopathy of prematurity (ROP), which often presents with bronchopulmonary dysplasia (BPD), is among the most common morbidities affecting extremely premature infants and is a leading cause of severe vision impairment in children worldwide. Activations of the inflammasome cascade and microglia have been implicated in playing a role in the development of both ROP and BPD. Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is pivotal in inflammasome assembly. Utilizing mouse models of both oxygen-induced retinopathy (OIR) and BPD, this study was designed to test the hypothesis that hyperoxia induces ASC speck formation, which leads to microglial activation and retinopathy, and that inhibition of ASC speck formation by a humanized monoclonal antibody, IC100, directed against ASC, will ameliorate microglial activation and abnormal retinal vascular formation.

Methods

We first tested ASC speck formation in the retina of ASC-citrine reporter mice expressing ASC fusion protein with a C-terminal citrine (fluorescent GFP isoform) using a BPD model that causes both lung and eye injury by exposing newborn mice to room air (RA) or 85% O 2 from postnatal day (P) 1 to P14. The retinas were dissected on P14 and retinal flat mounts were used to detect vascular endothelium with AF-594-conjugated isolectin B4 (IB4) and citrine-tagged ASC specks. To assess the effects of IC100 on an OIR model, newborn ASC citrine reporter mice and wildtype mice (C57BL/6 J) were exposed to RA from P1 to P6, then 75% O 2 from P7 to P11, and then to RA from P12 to P18. At P12 mice were randomized to the following groups: RA with placebo PBS (RA-PBS), O 2 with PBS (O 2 -PBS), O 2 + IC100 intravitreal injection (O 2 -IC100-IVT), and O 2 + IC100 intraperitoneal injection (O 2 -IC100-IP). Retinal vascularization was evaluated by flat mount staining with IB4. Microglial activation was detected by immunofluorescence staining for allograft inflammatory factor 1 (AIF-1) and CD206. Retinal structure was analyzed on H&E-stained sections, and function was analyzed by pattern electroretinography (PERG). RNA-sequencing (RNA-seq) of the retinas was performed to determine the transcriptional effects of IC100 treatment in OIR.

Results

ASC specks were significantly increased in the retinas by hyperoxia exposure and colocalized with the abnormal vasculature in both BPD and OIR models, and this was associated with increased microglial activation. Treatment with IC100-IVT or IC100-IP significantly reduced vaso-obliteration and intravitreal neovascularization. IC100-IVT treatment also reduced retinal microglial activation, restored retinal structure, and improved retinal function. RNA-seq showed that IC100 treatment corrected the induction of genes associated with angiogenesis, leukocyte migration, and VEGF signaling caused by O 2 . IC100 also corrected the suppression of genes associated with cell junction assembly, neuron projection, and neuron recognition caused by O 2 .

Conclusion

These data demonstrate the crucial role of ASC in the pathogenesis of OIR and the efficacy of a humanized therapeutic anti-ASC antibody in treating OIR mice. Thus, this anti-ASC antibody may potentially be considered in diseases associated with oxygen stresses and retinopathy, such as ROP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxygenRetinopathy of PrematurityAnimalsMiceAntibodies, Monoclonal, HumanizedMice, Inbred C57BLAnimals, NewbornDisease Models, AnimalHumansHyperoxiaRetinaCARD Signaling Adaptor ProteinsMice, TransgenicRetinal NeovascularizationMicroglia

Stichwörter der Autor:innen

ASCIC100MicrogliaOxygen-induced retinopathyTranscriptome

Substanzen

OxygenAntibodies, Monoclonal, HumanizedCARD Signaling Adaptor Proteins

Autor:innen und Institutionen

  • Department of Pediatrics/Division of Neonatology, Batchelor Children's Research Institute and Holtz Children's Hospital, University of Miami Miller School of Medicine, P. O. Box 016960, Miami, FL, 33101, USA.
  • The Miami Project to Cure Paralysis and Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Byers Eye Institute at Stanford University, Palo Alto, CA, USA.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Yuan, H., Chen, S., Duncan, M. R., de Rivero Vaccari, J. P., Keane, R. W., Dalton Dietrich, W., Chou, T. H., Benny, M., Schmidt, A. F., Young, K., Park, K. K., Porciatti, V., Elizabeth Hartnett, M., & Wu, S. (2024). IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice. Angiogenesis. https://doi.org/10.1007/s10456-024-09917-9

Vancouver

Yuan H, Chen S, Duncan MR, de Rivero Vaccari JP, Keane RW, Dalton Dietrich W, et al. IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice. Angiogenesis. 2024. doi:10.1007/s10456-024-09917-9

BibTeX
@article{Yuan2024,
  author = {Yuan, Huijun and Chen, Shaoyi and Duncan, Matthew R and de Rivero Vaccari, Juan Pablo and Keane, Robert W and Dalton Dietrich, W and Chou, Tsung-Han and Benny, Merline and Schmidt, Augusto F and Young, Karen and Park, Kevin K and Porciatti, Vittorio and Elizabeth Hartnett, M and Wu, Shu},
  title = {IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice},
  journal = {Angiogenesis},
  year = {2024},
  doi = {10.1007/s10456-024-09917-9}
}
Kostenlos starten →